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Abstract
Macrophage Migration Inhibitory Factor (MIF) is a key mediator of inflammatory responses and innate immunity and has
been implicated in the pathogenesis of several inflammatory and autoimmune diseases. The oligomerization of MIF, more
specifically trimer formation, is essential for its keto-enol tautomerase activity and probably mediates several of its
interactions and biological activities, including its binding to its receptor CD74 and activation of certain signaling pathways.
Therefore, understanding the molecular factors governing the oligomerization of MIF and the role of quaternary structure in
modulating its structural stability and multifunctional properties is crucial for understanding the function of MIF in health
and disease. Herein, we describe highly conserved intersubunit interactions involving the hydrophobic packing of the side
chain of Leu46 onto the b-strand b3 of one monomer within a hydrophobic pocket from the adjacent monomer constituted
by residues Arg11, Val14, Phe18, Leu19, Val39, His40, Val41, Val42, and Pro43. To elucidate the structural significance of
these intersubunit interactions and their relative contribution to MIF’s trimerization, structural stability and catalytic activity,
we generated three point mutations where Leu46 was replaced by glycine (L46G), alanine (L46A) and phenylalanine (L46F),
and their structural properties, stability, oligomerization state, and catalytic activity were characterized using a battery of
biophysical methods and X-ray crystallography. Our findings provide new insights into the role of the Leu46 hydrophobic
pocket in stabilizing the conformational state of MIF in solution. Disrupting the Leu46 hydrophobic interaction perturbs the
secondary and tertiary structure of the protein but has no effect on its oligomerization state.
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Introduction
Macrophage Migration Inhibitory Factor (MIF) is a ubiquitous
multifunctional protein and a key player in the inflammatory
response and innate immunity. MIF was first identified in the
1960s as a T-cell cytokine involved in the delayed type
hypersensitivity and several macrophage functions, including
secretion and production of proinflammatory cytokines [1,2].
During the last two decades MIF has been shown to be involved in
a wide range of cellular processes, e.g. transcriptional regulation of
inflammatory gene products [3], cell cycle control [4,5], modu-
lation of cell proliferation and differentiation [6], regulating
glucocorticoı¨d activity [7], inactivation of p53 tumor suppressor
factor [8] and signal transduction, and emerged as an important
player in the molecular mechanisms underlying the pathogenesis
of several inflammatory autoimmune diseases including arthritis
[9,10,11], multiple sclerosis [12,13], diabetes [14], sepsis
[15,16,17], atherosclerosis [18] and oncogenesis
[19,20,21,22,23,24,25]. The role of MIF in these diseases has
been confirmed in several animal models using genetic, immuno-
logical and pharmacological approaches.
Unlike other cytokines, MIF also functions as an enzyme, and
exhibits hormone-like activities [26,27,28]. MIF has two enzy-
matic activities: an evolutionarily well conserved keto-enol
tautomerase activity [29,30] and a thiol-protein oxido-reductase
activity that is mediated by the C56ALC59 motif [31,32]. However,
the physiological relevance of these activities and their role in
regulating the function of MIF in health and disease remain
controversial [33,34]; the physiological substrates for both catalytic
activities are yet to be discovered.
X-ray structural studies have consistently shown that MIF exists
as a homotrimer [35]. Data from size-exclusion chromatography
[36], analytical ultracentrifugation [36,37] and light scattering
[36] are also consistent with the trimer as the predominant species
in solution, although a number of reports suggest that MIF may
populate a mixture of trimeric, dimeric and monomeric states at
physiological concentrations [38,39]. Each MIF monomer consists
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of 114 amino acids and is composed of two anti-parallel a-helices
packed against a four-stranded b-sheet. The trimer is held together
by a range of intersubunit interactions involving key residues from
two primary regions within each monomer [36]; i) the inner b-
strand b3 of each monomer (Figure 1A); ii) the C-terminal region
of MIF, including the C-terminal b-hairpin comprising residues
105–114 (b6, b7), is involved in several intersubunit stabilizing
interactions. Previous studies from our laboratory and others
[36,40,41] have assessed the importance of the conformational
properties of this region on the oligomerization and functional
properties of huMIF. C-terminal deletions (110–114 or 105–114)
or disruption of the conformational properties of this region, via
insertion of a proline residue, result in loss of MIF’s enzymatic
activity [36,40,41] and reduction in macrophage activating
properties [41]. At the structural level, these mutations were
shown to induce significant tertiary structure changes within the
MIF trimer without altering its oligomerization state and receptor
(CD74) binding properties [36].
Understanding the molecular factors that govern trimer
formation and the role of oligomerization in modulating its
structural stability and attenuating its biochemical and biological
properties is crucial for understanding MIF’s function in health
and disease. MIF trimer formation is required for its catalytic
activity. The tautomerase active site is formed at the monomer-
monomer interface and involves amino acid residues from both
neighbouring subunits [42] and the N-terminal catalytic proline
residue (Pro1) [40,42,43]. Furthermore, studies using recombinant
MIF suggest that MIF’s binding to its receptor CD74 involves the
trimer [44]. Therefore, small molecules or mutations that inhibit
or disrupt trimer formation should allow for simultaneous
inhibition of its catalytic activity and receptor binding, thus
providing more effective antagonists of MIF’s proinflammatory
activity compared to tautomerase inhibitors or neutralizing
antibodies. Herein, we describe novel intersubunit interactions
involving the hydrophobic packing of leucine 46 (Leu46) side
chain on the b-strand b3 of one monomer within a hydrophobic
pocket from the adjacent monomer constituted by residues Arg11,
Val14, Phe18, Leu19, Val39, His40, Val41, Val42, and Pro43
(Figure 1). Analysis of MIF sequences and high resolution X-ray
structures of MIF reveals that the formation of this hydrophobic
pocket is highly conserved (.95%) or exhibits highly conservative
mutations across mammalian (human), rodent (rat and mice) and
amphibian (frog) MIF, suggesting that it may play critical roles in
modulating MIF trimerization and stability. Interestingly, in
nematode MIF the hydrophobic interaction is replaced by tight
electrostatic interactions, where Leu46 is substituted by an
arginine, and the hydrophobic/basic residues constituting the
pocket, Arg11 Leu19 and His40 are replaced by the acidic residues
Asp11, Glu19 and Glu40 respectively (Figure 1D). To elucidate
the structural significance of these intersubunit interactions and
their relative contribution to MIF’s trimerization, structural
stability and catalytic activity, we generated three point mutations
where leucine 46 (Leu46) was replaced by glycine (L46G), alanine
(L46A) and phenylalanine (L46F) (Figure 2A–D), and their
structural properties and stability, oligomerization state, and
catalytic activity were characterized using a battery of biophysical
methods and X-ray crystallography. In addition, to further analyze
the global structural behavior of wild-type (wt) and mutants
huMIF, and to investigate the dynamic properties at the atomic
scale, we carried out ,100 ns molecular dynamic simulations.
Our results reveal that Leu46 intersubunit interactions play
important role in stabilizing the secondary and tertiary structure
of MIF. Nonetheless, sedimentation velocity analytical ultracen-
trifugation, NMR and X-ray crystallography provide strong
evidence that these hydrophobic interactions do not influence
the oligomerization state of MIF.
Materials and Methods
Materials
Polymerase chain reaction (PCR) and other molecular biology
reagents were purchased from Stratagene unless stated otherwise.
DNA mini and maxi prep reagents were purchased from Qiagen
and oligonucleotide primers from Microsynth. Escherichia coli
BL21 DE3 cells, rabbit monoclonal anti-huMIF and goat anti-
rabbit ALEXA Fluor 680 were purchased from Invitrogen.
Miscellaneous chemicals were from Sigma-Aldrich Chemicals
and were of the highest grade commercially available. Isopropyl 1-
thio-P-D-galactopyranoside (IPTG) was purchased from Appli-
chem. 15N-ammonium chloride was purchased from CIL (Cam-
bridge Isotope Laboratories, Switzerland).
Site-directed Mutagenesis of Leu46 Mutants
Wt huMIF cloned into the pET11b expression vector was a
kind gift from Prof Richard Bucala. L46A, L46G and L46F
huMIF mutants were engineered by site directed mutagenesis
using mutagenesis kit from Stratagene. All mutants were cloned
from huMIF-pETllb by DNA amplification. Polymerase chain
reactions (PCR) were performed in a Px2 Thermal Cycler (Catalys
AG, a Promega Company). Initial denaturation was for 30 s at
95uC followed by 16 cycles of 30 s at 95uC, 1 min at 55uC, and
(1 min/Kb of plasmid length) at 68uC using 2.5 units of Pfu Turbo
DNA polymerase (Stratagene). Primers designed were 59 GTC
CCT GAT CAG TTC ATG GCC TTC GGC 39 (sense), 59 GCC
GAA GGC CAT GAA CTG ATC AGG GAC 39 (antisense) for
L46F huMIF; 59 GTC CCT GAT CAG GGC ATG GCC TTC
GGC 39 (sense) and 59 GCC GAA GGC CAT GCC CTG ATC
AGG GAC 39 (antisense) for L46G huMIF; and 59 GTC CCG
GAC CAG GCC ATG GCC TTC GGC 39 (sense) and 59 GCC
GAA GGC CAT GGC CTG GTC CGG GAC 39 (antisense) for
L46A huMIF. Mutants DNA sequences were confirmed by
sequencing at Microsynth. Note that residue numbering through-
out this manuscript starts at Pro-1 and not at the cleaved initiator
methionine.
Protein Expression and Purification
Expression and purification of wt and mutants were carried out
as described previously [36]. The wt and three mutants are
expressed as soluble proteins in Escherichia coli (E. coli), and the
purity and protein identity were verified by sodium dodecyl sulfate
polyacrylamide gel electrophoresis (SDS-PAGE) Coomassie blue
staining, reversed-phase high performance liquid chromatography
(HPLC) and matrix-assisted laser desorption ionization time of
flight (MALDI-TOF) mass spectrometry. All proteins were found
to be more than 95% pure; mass spectrometry analyses revealed
single peaks with the expected average molar masses of
12345 g.mol21, 12303 g.mol21, 12379 g.mol21 and
12289 g.mol21 for wt, L46A, L46F and L46G respectively. For
preparation of uniformly 15N single-labeled and 13C/15N-double-
labeled huMIF, samples were prepared by growing the bacteria in
M9 minimal media containing 15N-ammonium chloride (1 g/L) as
the only nitrogen source, or 15N-ammonium chloride and 13C-
glucose in case of double labelled samples, supplemented with
minerals and cofactors [45].
MIF Keto-enol Tautomerase Activity
The keto-enol tautomerase activity of MIF was measured using
the hydroxyphenylpyruvate substrate as described previously
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[36,46]. Total enzyme concentration in the reaction mixture was
100 nM and the catalysis was followed for one minute using the
CARY 100 Bio UV-Visible Spectrophotometer at 475 nm. Initial
rate of the catalytic activity was calculated within the first 30 s of
the reaction. Data calculated are the average of at least three
measurements.
Probing the Structural Stability of MIF by Far-UV Circular
Dichroism (CD) and Fluorescence Spectroscopy
The far-UV (195–250 nm) CD spectra of wt and huMIF
mutants in PBS 1X (137 mM NaCl, 10 mM Phosphate, 2.7 mM
KCl, pH 7.4) were recorded at room temperature using a 0.1 cm
quartz cell and Jasco J-815 CD Spectrometer equipped with a
thermostated cell holder. Data were acquired at a step size of
0.5 nm, an averaging time of 0.25 to 2 s, a bandwidth of 1 nm,
and an average of five scans recorded to generate the data
reported in units of mean molar ellipticity per residue. Thermal
denaturation (TD) studies were performed by recording the mean
molar ellipticity at 218 nm for each protein (5–30 mM) in PBS 1X
as a function of the temperature (20–98uC). Data were collected at
218 nm, using a temperature slope of 2uC/min with data pitch of
0.2uC and a bandwidth of 1 nm. Unfolding curves are expressed
as the percentage of unfolded protein relative to native protein (i.e.
the change in ellipticity at 218 nm) over the increase in
temperature. Guanidinium hydrochloride (GdnHCl) induced
denaturation studies were performed by recording the mean
molar ellipticity per residue as a function of wavelength (195–
240 nm) and GdnHCl concentration. The spectra represent the
average of at least 3 samples (10 mM, in PBS 1X buffer at room
temperature). Data were collected at 218 nm with a time constant
of 8 s and a bandwidth of 1 nm. Unfolding curves are expressed as
the percentage of unfolded protein relative to native protein
Figure 1. The Leu46 hydrophobic pocket is highly conserved across MIF species. The three MIF monomers are represented as cartoons
and are colored in pink, cyan and blue. (A) Side view of the trimer illustrating the different intersubunit interactions. Two main regions within each
monomer were shown to be responsible for the protein trimerization: each subunit interacts with one neighbouring monomer through tight
interactions involving the inner b-strand (b3) and with the other neighbouring monomer though the C-terminal b-hairpin (b6 and b7). The C-terminal
b-hairpin comprises two major types of interactions: 1) intersubunit b-sheet, and 2) salt-bridge interactions. The b-strand b3 contributes to trimer
stabilization through two types of contacts: 1) intersubunit b-sheet formation, and 2) hydrophobic interactions between the side chain of Leu46
localized on the b-strand b3 and a hydrophobic pocket from the adjacent monomer constituted by residues Arg11, Val14, Phe18, Leu19, Val39, His40,
Val41, Val42, Pro43. (B) Side view of the trimer illustrating the distance between the Leu46 hydrophobic pocket and the enzymatic site. (C) Top view
of huMIF showing the three hydrophobic pockets where Leu46 from adjacent monomers are packed. Each pocket is represented with the same color
as the subunit it belongs to, Leu46 are represented as stick models licorice and colored with the same subunit color. Structural data according to
Orita et al. [51], PDB code: 1GD0. (D) Hydrophobic pocket structure homology between different MIF species. Structural data were generated using
the following PDB files: 1GD0 (human MIF, [51]); 1MFI (mouse MIF, [68]); 1FIM (rat MIF, [69]); 2OS5 (Ancylostoma ceylanicum MIF, [70]); 3B64
(Leishmania parasite MIF, [71]); 1UIZ (Xenopus laevis MIF, [72]). Amino acids are represented on the figure with one-letter codes.
doi:10.1371/journal.pone.0045024.g001
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(i.e. the normalized change in ellipticity at 218 nm) over GdnHCl
concentration.
GdnHCl induced denaturation studies were also performed by
monitoring changes in the tyrosine and tryptophan fluorescence
emission maximum of wt and Leu46 mutants as a function of
GdnHCl concentration. The spectra represent the averages of at
least 3 scans performed on the protein sample (3 mM) in PBS 1X
incubated overnight at room temperature with different concen-
trations of GdnHCl. The wt and huMIF mutants were excited at
295 nm and 280 nm. Fluorescence emission was acquired over a
wavelength range of 290–450 nm using a LS 55 Perkin Elmer
Fluorescence Spectrometer. Unfolding curves are expressed as the
percentage of unfolded protein relative to native protein (i.e. the
change in maximum fluorescence emission intensity as a function
of GdnHCl concentration).
Quaternary Structure Determination by Analytical
Ultracentrifugation (AUC) and Light Scattering
Analytical ultracentrifugation experiments were performed on
purified and dialyzed MIF samples at 5, 10 and 30 mM in PBS 1X
buffer on a Beckman Optima XL-A analytical ultracentrifuge.
Sedimentation velocity experiments were carried out at 20uC
using 380–400 mL of protein solution. Data were recorded at rotor
speeds of 50,000 rpm in continuous mode at 21uC with a step size
of 0.003 cm. The experimentally determined partial specific
volume of 0.765 mL/mg was used for calculating the molecular
weights of wt and mutants huMIF [37]. Given that this value was
determined only for wt huMIF and for comparison purposes, the
molecular weights of the mutants were also determined using the
calculated (using the program SEDNTERP [37]) partial specific
volumes of 0.7336 mL/g, 0.7340 mL/g, and 0.7332 mL/g for
L46A huMIF, L46F huMIF and L46G huMIF respectively. The
sedimentation velocity absorbance profiles were analyzed as a C(s)
distribution of the Lamm equation using SEDFIT [47]. To obtain
the molecular weights, the molar mass distributions c(M) were
obtained by transforming the corresponding c(s) using SEDFIT.
Static light scattering experiments were carried out on
purified MIF samples (20–30 mM in PBS 1X) in volumes of
100 mL. All measurements were performed at room temperature
on a DAWN HELEOS II Multi-angle light scattering detector
Figure 2. Disrupting the hydrophobic interactions via mutating Leu46 alters the structural stability of MIF. (A) Leu46 hydrophobic
pocket of wt huMIF. VMD representations of the hydrophobic pocket, where Leu46 is mutated to a phenylalanine (L46F) (B), alanine (L46A) (C), or
glycine (L46G) (D). (E-H): The three Leu46 mutants are structurally less stable than the wild type protein, but retain the same overall secondary
structure. (E) Far-UV CD spectra of wt and Leu46 mutants. (F) Thermal denaturation of wt and Leu46 mutants (at 20 mM) followed by far-UV CD at
218 nm. (G) GdnHCl denaturation studies monitored by far-UV CD at 218 nm and fluorescence spectroscopy (H), excitation wavelength: 295 nm,
protein concentration: 10 mM. All spectroscopic experiments were performed in PBS 1X, pH 7.4 buffer. Black lines, wt MIF; blue lines, L46F MIF; red
lines, L46A MIF; green lines: L46G MIF.
doi:10.1371/journal.pone.0045024.g002
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(Wyatt Technology Corp, Santa Barbara CA). The system is
also equipped with UV (Agilent 1200 VWD) and refractive
index (Wyatt Optilab rEX) detectors. Absolute MWs were
determined using ASTRA version 5.3 from Wyatt Technologies,
using refractive index-based online protein concentration mea-
surement, based on protein dn/dc of 0.185 mL/g.
NMR Spectroscopy
NMR spectra were acquired at 27uC on Bruker Avance
600 MHz and 700 MHz NMR spectrometers using a triple-
resonance cryo-probe equipped with z-axis self-shielded gradient
coils. All NMR measurements were done with 300–500 mM
sample concentration dissolved in PBS 1X buffer (pH 7.0) with
10% D2O. Spectra were processed with TopSpin (Bruker Biospin,
Germany) and NMRPipe [48], and visualized and analyzed with
Sparky 3.1 [49].
Two-dimensional 1H-15N heteronuclear single quantum coher-
ence (HSQC) experiments were recorded for wt, L46A, L46F and
L46G MIF. Spectral widths were 8389 Hz (9765 Hz for
700 MHz) in the 1H dimension and 1581 Hz (1945 Hz for
700 MHz) in the 15N dimension. Resonance assignments were
previously published for the same buffer system [50]. Mean
weighted 1H215N chemical shift differences between different
MIF variants were calculated according to the relationship Dd =
({(Dd1H)2+ [(Dd15N)/5]2}1/2)/2. Changes were mapped on the
crystal structure using PDB entry 1GDO [51] (1.5 A˚ resolution)
and PyMOL.
Mass Spectrometry
Mass spectrometric analysis of huMIF was performed by
matrix-assisted laser desorption ionization MALDI MS using a
linear positive ion mode on an ABSciex 4800 (in the EPFL
Proteomics Core Facility). The mass spectrometer was calibrated
using a mixture of bovine insulin (5734 Da), ubiquitin (8565 Da),
and cytochrome c (12361 Da). Sample preparation: after desalting
huMIF sample on a StageTip C18 (Proxeon), one volume of
sample was mixed with one volume of matrix. Matrix solution
consists of 14 mg/mL of sinapinic acid in 50:50 water:acetonitrile
+0.1% trifluoroacetic acid. A two-layer sample preparation has
been selected for the MW analysis.
X-ray Crystallography
MIF mutants (L46A, L46G and L46F) were crystallized using
the hanging drop vapor diffusion method. Each of the mutants
L46A, L46G and L46F (2.1 mM, 1.2 mM and 3.4 mM,
respectively) was mixed with the reservoir solution containing
different concentrations of Ammonium sulfate (1.6 to 2.6 M) in
0.1 M Tris (pH 7.5) and 3% isopropanol. Plates were incubated at
18uC and crystals were formed within 30 min to several hours. For
data collection, crystals were flash-frozen in liquid nitrogen after
being placed in a cryo-protectant containing 25% PEG 400. Data
were collected at the Swiss Light Source (SLS, PXI & PXIII). Data
were processed with XDS [52]. The mutants crystals belonged to
the P 21 21 21 space group, with three molecules per asymmetric
unit.
The structures of MIF mutants were solved by molecular
replacement using previously published MIF structure (PDB code
1GD0) as template [51]. Refinement was carried out using
REFMAC5 [53], part of the CCP4i program suite [54]. Manual
adjustments of the model were made in COOT [55]. Coordinates
and structure factors for the L46A, L46G and L46F structures
have been deposited in the Protein Data Bank (accession code
4EVG, 4ETG and 4EUI, respectively). The structure of wt huMIF
with PDB code 3DJH was selected for our comparative analysis
because of its high resolution (1.25 A˚).
Computational Studies
Classical Molecular Dynamics (MD) simulations were based on
the crystal structure of huMIF (Protein Data Bank code 1GD0)
obtained at 1.5 A˚ resolution [51]; residues corresponding to the
His-tag sequence were removed from the PDB file. Four model
systems of the trimeric structure of huMIF were considered: wt,
L46A, L46F and L46G. The protonation state of the titratable
groups were set as in Orita et al. [51]. MD simulations were
performed using a parallel version of the GROMACS 4 package
[56,57] using the AMBER/parm98 [58] and SPC [59] all-atom
force fields for the protein and water, respectively. All systems are
subjected to periodic boundary conditions in the three directions
of the Cartesian space and the size of the box is
7.61 nm67.32 nm67.56 nm. After 2 ns of MD equilibration,
70, 80, 90 and 72 ns of MD simulation for wt huMIF, L46F
huMIF, L46A huMIF and L46G huMIF were collected,
respectively. Normal conditions (T= 300 K, P= 1 bar) were
achieved by coupling the systems with Berendsen thermostat
[60] with a coupling constant tau = 1.0 ps and Berendsen barostat
[60] with compressibility of 4.5 10210 bar21 in all three
dimensions. Electrostatic interactions were calculated with the
Ewald particle mesh method [61]. A 12 A˚ cutoff for van der Waals
interactions was used. Bonds involving hydrogen atoms were
constrained using the SHAKE algorithm [62]. All data analysis
was done using GROMACS [56,57] utilities and all molecular
images were made with Visual Molecular Dynamics (VMD) [63].
Results
To elucidate the role of intersubunit interactions involving
Leu46 on the structure and stability of MIF, we compared the
structural stability, and biophysical properties of wt, L46A, L46F
and L46G mutants at the secondary, tertiary and quaternary
structure levels.
Leu46 Mutants Display Similar Secondary Structure but
are Structurally Less Stable than wt huMIF
We first probed the effect of mutating Leu46 residue on MIF’s
conformation by far UV CD spectroscopy. Similar to the wt
protein, all three mutants display a broad spectrum with negative
ellipticity between 209 nm and 222 nm consistent with a
conserved mixture of a-helix and b-sheet structures (Figure 2E).
The relative stability of the secondary structure of Leu46 mutants
was then assessed by monitoring the protein denaturation during
heat-induced unfolding and in presence of chaotropic salts.
Thermal unfolding monitored by far UV CD at 218 nm
demonstrated that disruption of Leu46 hydrophobic site induces
a clear destabilization of MIF structure stability (Figure 2F). Wt
huMIF unfolds with an apparent Tm value of 78uC at 10 mM,
whereas L46F, L46A and L46G huMIFs began to undergo
conformational changes at lower temperatures and displayed
apparent Tm values of 73uC, 69uC and 61uC respectively at
10 mM. It is noteworthy that L46G huMIF presents a two-step
melting curve with inflexion points at 60uC and 72.2uC. L46G
aggregates could already be observed at 65uC. Over the protein
concentration range of 5 to 30 mM, we observed virtually identical
heat denaturation curves and Tm values for each of the wt protein
and Leu46 variants respectively (Figure S1). Since huMIF
aggregates as it unfolds, thermal denaturation of all mutants was
irreversible.
Leucine 46 Hydrophobic Pocket
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To further probe the effect of Leu46 mutations on the structural
stability of MIF, we monitored the unfolding of wt, L46G, L46A
and L46F by far-UV CD at 218 nm (Figure 2G) as a function of
GdnHCl. Consistent with the thermal denaturation assays,
cooperative unfolding was observed for each huMIF species with
the same stability pattern: wt, L46F, L46A and L46G huMIF
showed denaturation midpoints, apparent Cm values of
1.8260.02 M, 1.6160.01 M, 1.4060.01 M and 1.0960.05 M,
respectively at 10 mM. We then performed GdnHCl unfolding
experiments where we determined the stability of MIF at the
tertiary structure level by recording the maximum fluorescence
emission intensity upon excitation of Tryptophan at 295 nm as a
function of GdnHCl (Figure 2H). The order of stability observed
by fluorescence is consistent with the thermal denaturation and
far-UV CD GdnHCl studies: measured unfolding midpoints at
3 mM were 1.4360.07 M, 1.2760.02 M, 1.0960.08 M and
1.1460.07 M for wt huMIF, L46F huMIF, L46A huMIF and
L46G huMIF respectively. Nonetheless, Cm values measured by
fluorescence spectroscopy are fairly lower than those measured by
far-UV CD, which can be explained by the fact that the only
tryptophan residue of a MIF subunit is located within the C-
terminus b-hairpin, which is more accessible and a structurally
more flexible region of the protein. All GdnHCl experiments
showed that the L46G variant is the least stable mutant and does
not follow a two-state unfolding mechanism. Together, these data
suggest that interaction of Leu46 from one monomer with the
hydrophobic pocket from the adjacent subunit is critical to the
structural stability of the trimer.
Leu46 Mutants are All Trimers
Since the Leu46 pocket is located at the monomer-monomer
interface and mutating Leu46 destabilizes the trimer, we first
sought to determine whether the Leu46 mutations alter the
quaternary structure of MIF by analytical ultracentrifugation/
sedimentation velocity experiments (Figure 3). All huMIF
variants sediment predominantly as trimers; wt and L46F exhibit
a sedimentation coefficient of 3.15 S while L46A and L46G
sediment with an s value of 3.3 S. To determine if the effect of
Leu46 mutations on MIF’s oligomerization is concentration
dependent, we performed sedimentation velocity studies on all
proteins over the concentration range of 5–50 mM. At all
concentrations, wt and Leu46 mutants sediment predominantly
as a single species with s values and molecular masses
corresponding to that of the trimer (Figure S2).
To confirm the above results and to examine the consequences
of Leu46 mutations on the quaternary structure of huMIF under
native conditions, we performed static light scattering studies on wt
and mutants at protein concentration of 20 mM. Static light
scattering and refractive index detection represent a reliable tool to
monitor for structural properties of proteins and determination of
their accurate molecular weight. Analyses of our LS data
demonstrated that all MIF variants correspond to trimeric
structures with MW ,33 KDa.
Probing the Importance of Leu46 Hydrophobic Pocket
Stability on the Functional Properties of huMIF
Inspired by the proximity of the tautomerase active site and the
hydrophobic pocket (Figure 1B), we then sought to assess
whether destabilization of Leu46 pocket could be transmitted to
the catalytic site and affects its conformation. Thus, kinetic
parameters of wt huMIF and Leu46 mutants were measured using
the hydroxyphenylpyruvate as a substrate (Table 1). Our data
showed that L46A mutation has almost no effect on MIF’s
catalytic activity and affinity towards its substrate (Km,L46A
,1.0460.06 mM, Km,wt ,1.0560.04 mM; Kcat,L46A
,52.762.8 s21, Kcat,wt ,52.964.8 s21). The L46G and L46F
mutants had opposite, yet small effects on MIF’s enzymatic
efficiency and affinity. The L46G mutant exhibits a slightly
increased (,10%) Km value (1.1660.08 mM) indicating a lower
affinity of the mutant to the hydroxyphenylpyruvate. However,
catalytic efficiency is unchanged relative to the wt (Kcat/
Km=48.8 s
21.mM21). In contrast, the L46F mutant showed
almost 10% increased affinity towards the substrate
(Km= 0.94 mM) and a ,1.5 fold higher catalytic constant
(Kcat = 81.1 s
21), leading to an enhancement of the protein
enzymatic efficiency. Our data suggest that Leu46 intersubunit
interactions play a role in modulating the catalytic activity of MIF.
Perturbing the hydrophobic interactions within the Leu46 pocket,
i.e. increasing or decreasing the hydrophobic interactions, has
different effects on MIF’s catalytic efficiency and affinity towards
its substrate (Table 1).
Structural Characterization by NMR Spectroscopy
The effect of disrupting intersubunit hydrophobic interactions,
via mutating Leu46, on the structure of MIF, was also assessed
using NMR spectroscopy. NMR chemical shifts strongly depend
on the chemical environment and are therefore very sensitive to
structural changes. Figure 4 shows chemical shift changes
induced by mutation of Leu46 into alanine and phenylalanine.
The largest chemical shift changes were observed in the region of
residues 1–20 (in particular 12–20) and 38–43 in the case of L46A
relative to the wt protein. In the case of L46F, chemical shift
changes were observed for residues 12–20 and 39–42, and
additional chemical shift changes (compared to L46A) were
observed for residues 21–23, 45–49 and residues 58, 60
(Figure 4B, left panel and Figure S3). L46A and L46G behave
very similar with the exception of Val42, which is in direct spatial
proximity to the side chain of residue 46 of another monomer
(Figure 4B, right panel). It is noteworthy that most of the residues
Figure 3. Mutation of Leu46 does not alter the quaternary
structure of MIF. Sedimentation rate distributions as determined by
Analytical Ultracentrifugation/Sedimentation Velocity experiments indi-
cating similar sedimentation rates for the wt and Leu46 huMIF mutants
(15 mM in PBS 1X, pH 7.4 buffer).
doi:10.1371/journal.pone.0045024.g003
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having marked dissimilar behavior between L46F and L46A/
L46G mutants belong to the hydrophobic pocket; notably:
residues Val14, Phe18, Val39, His40, Val42 (Figure 4B). For
better visualization, residues from L46A and L46F huMIF bearing
chemical shift deviations larger than +/20.2 ppm in 15N or +/
20.02 ppm in the 1H dimension relatively to wt huMIF are
mapped onto the crystal structure of wt huMIF (PDB code 1GD0)
(Figure 4C).
Structural Studies by X-ray Crystallography
To understand the role of Leu46 mutations on the three-
dimensional structure of MIF, we also determined the crystal
structures of L46F, L46A and L46G huMIF at 1.70 A˚, 1.70 A˚ and
1.60 A˚, respectively. Similar to the wild type species, Leu46
mutants crystallized as homotrimeric proteins with dimensions of
approximately 35 A˚650 A˚650 A˚. No striking effect to the three-
dimensional structure was observed upon mutating Leu46
(Figure 5). Root mean square deviations from the initial wt
backbone structure are 0.167 A˚, 0.574 A˚ and 1.153 A˚ for L46F,
L46A and L46G respectively. Interestingly, these structural
deviations are consistent with the order of stability of the protein
observed by circular dichroism and fluorescence. Careful exam-
ination of the structure of MIF mutants suggests that substitution
of Leu46 by phenylalanine mutation has no significant effect on
the secondary structure of MIF but causes a slight distortion of b-
strand b3, whereas substitution by alanine (L46A) or glycine
(L46G) results in systematic perturbation of the protein’s
secondary structure at both the b-strand b3 and the loop located
at the N-terminus of a-helix (residues 10–14), in line with the
changes in NMR chemical shifts in this region (Figure 4A).
Additionally, L46G disruption of the hydrophobic pocket induces
additional structural changes at the C-terminus where the 3–10
helical structure is lost for a random coil structure (Figure 5). The
structural effects induced by these mutations correlate with -
the order of stability of the corresponding mutant protein at the
secondary and tertiary structure levels, where the L46G is the least
stable mutant and L46F is the most stable variant after the wt
(Figure 2). Close examination of the structures also revealed slight
perturbations of the hydrogen bonds at the interface of adjacent
monomers, between b-strands b3 and b2 (Figure 5, Table 2).
Protein Conformational Fluctuations at the Leu46
Hydrophobic Pocket
To understand the dynamic properties of wt and Leu46 huMIF
mutants, as well as to better elucidate the molecular basis
underlying the effect of the Leu46 mutations, we carried out four
independent ,0.1 ms MD simulations on wt huMIF, L46F
huMIF, L46A huMIF and L46G huMIF, based on the crystal
structure of the wt protein (PDB code: 1GD0, see Method section).
Although the limited timescales of MD simulations (of the order of
,ms) do not capture large conformational rearrangements which
often involve timescales of $ ms, they can provide some insights
about the structural behavior of proteins in solution, at the
atomistic level.
Protein Conformational Fluctuations at the Leu46
Hydrophobic Pocket
The equilibrium states of the wt and Leu46 mutants, obtained
upon ,7 ns of MD equilibration do not largely differ from the
initial crystal structure (wt huMIF), based on the root mean square
displacements (RMSD). At equilibrium, the RMSD of the Ca
atoms fluctuates around an average value of ,1.5 A˚ with respect
to the X-ray structure (data not shown). On the other hand, the root
mean-square fluctuations (RMSF) of the residues in wt and Leu46
mutants are virtually similar, indicating that the overall fold of the
protein is well maintained (Figure S4). Nonetheless, wt huMIF
and all of Leu46 mutants show higher fluctuations in the region
between residues 13 and 18 (RMSF .1.5 A˚), which are located at
the N-terminus of the a-helix H1 and participate in the formation
of the hydrophobic pocket (Figure 1), suggesting a higher
mobility of this protein region compared to the rest of the protein.
In addition, residues 28–32 of L46F MIF, corresponding to the C-
terminus of the a-helix H1, exhibit larger mobility compared to
the other proteins, suggesting an accumulation of mechanical
strain due to higher steric repulsion upon mutating the Leu46 to
phenylalanine. The increased flexibility in this region is in
agreement with NMR spin relaxation measurements, which
showed that the residue stretches 17–22, 31–33, 51, 52, 55 and
72–75 experience internal motions on the nanosecond timescale
[50]. In addition, conformational exchange contributions were
observed by NMR spectroscopy for residues 62, 63 and 67, which
are close to the catalytic site.
Analysis of the MD simulations trajectory of the wt huMIF
suggests that the fluctuation of the hydrophobic pocket corre-
sponds to the oscillating motion of the a-helix H1 between
shortened and extended states (Figure 6A, B). Two different
parameters were used to measure the changes in the conforma-
tional properties of helix H1; 1) the angle between the Ca atoms of
residues Leu19Ca:Pro15Ca:Arg11Ca (Figure 6), located at the N-
terminus of H1, which provides a measure of the Leu46 pocket
enlargement and fluctuates between two distinct values, ,90u
(shortened a-helix H1) and ,120u (extended a-helix H1)
(Figure 6A, B); and 2) the hydrogen bond formation between
the polar H of residue Ser53 side chain from the extended a-helix,
and the carbonyl of residue Asp16 from the adjacent monomer
(distance fluctuates between ,2 and ,10 A˚) (Figure 6A, B). As
Table 1. Summarized enzymatic and biophysical data collection of wt and Leu46 huMIF mutants.
Enzymatic Activity AUC Circular Dichroism Fluorescence
Km (mM) Kcat (s21)
Kcat/Km
(s21.mM21)
Sedimentation
rate (S) Tm (6C) Cm (M)
Cm Ex.280 nm
(M) Cm Ex.295 nm (M)
Wt 1.0560.04 52.964.8 50.364.8 3.1360.05 7860.5 1.8260.01 1.3260.01 1.4360.01
L46A 1.0460.06 52.762.8 50.664.3 3.2860.06 69.260.5 1.4060.01 1.0860.01 1.0960.01
L46G 1.1660.08 56.867.9 48.867.8 3.2760.05 6160.5 1.0960.01 1.0060.01 1.1460.01
L46F 0.9360.02 81.167.9 87.268.7 3.1560.04 7360.5 1.6160.01 1.2360.01 1.2760.01
Each data represented is the average of three independent measurements; apparent Tm values reported are measured at protein concentrations ranging from 5 to
30 mM; apparent Cm values reported by circular dichroism and fluorescence are measured at protein concentration of 10 and 3 mM respectively.
doi:10.1371/journal.pone.0045024.t001
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Figure 4. NMR chemical shift perturbations by Leu46 mutants reveal higher fluctuation of the Leu46 pocket. (A) Normalized changes
in 1H, 15N chemical shifts of L46A and L46F MIF compared to the wild-type protein from wild-type huMIF. Normalized shift changes are calculated
according to !(DH2+(DN/5)2 ). (B) Two-dimensional representation of chemical shift deviations of L46F and L46G MIF from those of the L46A mutant.
The gray square is drawn at +/20.2 ppm in 15N, +/20.02 ppm in the 1H dimension and separates very small from larger chemical shift changes.
Arrows indicate residues belonging to the hydrophobic pocket. (C) Residues with chemical shift deviations larger than +/20.2 ppm in 15N,
+/20.02 ppm in the 1H dimension in L46F and L46A MIF (relative to wt MIF) are mapped onto the MIF crystal structure. Leu46 is shown as black
sphere, catalytic core residues (1, 32, 64) as blue sticks, residues with strong chemical shift changes are colored in red.
doi:10.1371/journal.pone.0045024.g004
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expected by observing the protein motion, the hydrophobic pocket
angle fluctuation is in perfect correlation with the hydrogen bond
formation, thus with the extension and shortening of helix H1.
When the hydrogen bond Ser53OH-AspCO is formed, the angle
Leu19Ca:Pro15Ca:Arg11Ca is 120u and the a-helix H1 is extended;
on the other hand, H1 is shortened when the hydrogen bond is
broken, and the angle is 90u. Extension and shortening of the a-
helix H1 coupled with the hydrophobic pocket angle fluctuations
were also observed for the three Leu46 mutants: L46A, L46G and
L46F. This peculiar motion of the a-helix in solution is in
agreement with the increased dynamics observed for residues 17–
22 by NMR spectroscopy [50]. In its crystal structure, wt huMIF
appears with a shortened state of the a-helix H1 [35].
Interestingly, Richardson et al. recently reported that MIF’s
Leishmania homologues, Leishmania Major MIF1 (LmjMIF1) and
Leishmania Major MIF2 (LmjMIF2) adopt extended a-helix H1 [64]
(Figure S5).
Discussion
Several lines of evidence support the importance of MIF’s
structure and catalytic activity in regulating some of its biochem-
ical and cellular functions. X-ray crystallography and NMR
studies have consistently revealed that MIF exists as stable non-
covalent homotrimer, although such studies were done at high,
unphysiological concentrations. Nevertheless, the molecular de-
terminants governing the oligomerization of MIF, as well as the
specificity of interaction between the different monomers in
solution are still being refined. Understanding these factors and the
relationship between the structure and functions of MIF are
essential for elucidating the molecular basis underlying its
multifunctional properties and developing targeted interventions
for prevention and therapy of MIF associated diseases. Our
approach was first to analyze the interface of MIF subunits and to
characterize the residues and key interactions contributing to the
specificity and stability of interaction between the different
subunits of the trimer.
Two Types of Interactions Stabilize the MIF Trimer
First, the extensive hydrophobic interface significantly contrib-
utes to the affinity between the different monomers, as well as to
the stability of the protein tertiary structure. Second, two main
regions (C-terminal b-hairpin and b-strand b3, Figure 1A) within
each monomer participate in several intersubunit polar and
hydrophobic interactions. The monomeric form of MIF is unstable
and mutations that disrupt MIF inter-monomer contacts lead to
misfolding and aggregation of the protein (Farah El-Turk PhD
thesis, EPFL) [36,65]. Therefore, it has not been possible to design
a monomeric variant of MIF or develop conditions to populate the
monomer in solution. The C-terminal b-hairpin has been
demonstrated to play an important role in the tertiary structure
and structural stability of the trimer, but is not essential for trimer
formation [36]. In the present report, we probed the hydrophobic
pocket, located at the N-terminus of the a-helix H1 (Figure 1A),
where the hydrophobic side chain of Leu46 from the adjacent
monomer is packed. This hydrophobic pocket is highly conserved
across MIF species (Figure 1D), suggesting it might play an
Figure 5. X-ray crystallography demonstrates that the three-dimensional structure of Leu46 mutants is very similar to the wt
protein. (A) Overlay of crystal structures of L46F (blue) L46A (green) and L46G (red). (B, C, D) Secondary structure disruptions induced by the Leu46
mutants are shown by superimposition of the wt human and L46F (B), L46A (C) and L46G (D) MIF monomers. Wt and Leu46 mutant monomers are
represented in pink and cyan respectively. Black arrows highlight the structural changes induced in the Leu46 variants.
doi:10.1371/journal.pone.0045024.g005
Table 2. Backbone root mean square deviation of Leu46 mutants based on the structure of wt huMIF, and hydrogen bonds
distances stabilizing the internal b-sheet involving b-strands b2 and b3 (Figure 1); percentages represent the increase/decrease of
the hydrogen bond distances in the mutants compared to the wt protein.
Wt huMIF L46F huMIF L46A huMIF L46G huMIF
RMSD (backbone) 0.163 A˚ 0.574 A˚ 1.153 A˚
G50:N I37:O 2.806 A˚ 2.831 A˚ (+0.9%) 2.856 A˚ (+1.8%) 2.774 A˚ (21.1%)
A48:O V39:N 2.902 A˚ 2.905 A˚ (+0.1%) 2.943 A˚ (+1.4%) 2.889 A˚ (20.4%)
A48:N V39:O 2.892 A˚ 2.933 A˚ (+1.4%) 2.869 A˚ (20.8%) 2.842 A˚ (21.7%)
x46:O V41:N 2.991 A˚ 3.125 A˚ (+4.4%) 3.052 A˚ (+2.0%) 2.949 A˚ (21.4%)
Q45:OE1 H40:NE2 2.865 A˚ 2.892 A˚ (+0.9%) - 2.808 A˚ (21.9%)
doi:10.1371/journal.pone.0045024.t002
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important role in stabilizing MIF intersubunit contacts and
modulating the structural and functional properties of the trimer.
In order to study its relevance to the structure and function of
MIF, we used single site-directed mutagenesis to perturb the
hydrophobic contacts within the non-polar pocket. Structural and
functional properties of wt huMIF, as well as L46F, L46A and
L46G mutants were then analyzed and compared using a wide
range of biophysical, biochemical and computational techniques.
Our study supports a structural model of MIF where the Leu46
pocket plays a role in modulating the structural stability and
tertiary structure of MIF.
Leu46 Hydrophobic Pocket Contributes to the Structural
Stability of MIF
As a first step towards understanding the contribution of Leu46
hydrophobic pocket towards MIF trimer stability, GdnHCl
titration and thermal melting studies (monitored by far-UV
circular dichroism and fluorescence techniques) demonstrated
that Leu46 mutants are structurally less stable than the wt protein
(Figure 2). Nevertheless, all three Leu46 mutants form stable
trimers (Figure 3). Replacing Leu46 by glycine has the most
dramatic effect on protein stability. This could be due to the fact
that replacing leucine by glycine results in the exposure of the
hydrophobic surface within the pocket, in addition to the increased
conformational freedom of glycine. These findings demonstrate
that Leu46 side chain interaction within a hydrophobic pocket
from the adjacent monomer is a key component of MIF
intersubunit interactions.
Similar to the wt Protein, Leu46 Mutants Exist as Stable
Trimers
There are three possible explanations for the decrease in MIF
stability upon Leu46 mutation and destabilization of the hydro-
phobic pocket: (a) dissociation of the trimer and subsequent
aggregation of unstable monomeric species, (b) alteration of MIF’s
conformation/tertiary structure or changes in the intrinsic
flexibility of the protein, (c) changes in the intrinsic flexibility of
the catalytic site [36]. To test whether Leu46 mutations alter
MIF’s quaternary structure, we determined the oligomeric state of
wt and Leu46 mutations by analytical ultracentrifugation/
sedimentation velocity and static light scattering. All four proteins
(wt, L46F, L46A and L46G) sedimented as a single species
corresponding to the trimer. Static light scattering, in agreement
with the analytical ultracentrifugation data, demonstrated that wt,
L46F, L46A and L46G exist as stable trimers. Finally, crystallo-
graphic data and enzymatic assays do not show any drastic
conformational change of the catalytic site or activity of MIF upon
Leu46 mutations. Therefore, any decrease in the stability of MIF
observed by circular dichroism and fluorescence may only be
attributed to the alteration in the stability or dynamic properties of
MIF’s tertiary and secondary structure.
Leu46 Hydrophobic Interaction is Essential to the
Secondary and Tertiary Structure Integrity of MIF
To test this hypothesis and to probe the influence of the Leu46
hydrophobic pocket destabilization on the structure of MIF, the
secondary and tertiary structural properties of the wt and mutants
MIF were investigated using NMR spectroscopy. The 2D 1H-15N
HSQC of wt and Leu46 mutant proteins resemble previously
observed NMR spectra [50,66] (Figure 4, Figure S3), which is
in concordance with our circular dichroism and oligomeric studies
data (Figure 2, 3). NMR chemical shifts are highly sensitive to the
chemical environment and provide excellent probes for the
secondary and tertiary structure of proteins. In our case, chemical
shift measurements demonstrate an extremely high similarity
between L46A and L46G huMIF, whereas the L46F mutant
exhibits a slightly different chemical shift pattern.
In agreement with our previous structural studies, X-ray crystal
structures of MIF variants demonstrate that the Leu46 mutants
Figure 6. a-helix H1 fluctuates between two states as observed during MD simulation. (A, B) Snapshots of the protein where the angle
between the Ca atoms of residues Leu19Ca:Pro15Ca:Arg11Ca is ,90u (shortened a-helix H1) and ,120u (extended a-helix H1), respectively.
doi:10.1371/journal.pone.0045024.g006
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conserve the same three-dimensional structure pattern as the wt
protein. Nonetheless, our NMR and crystallographic data provide
some insight into the possible structural basis underling the
proteins stability differences at the secondary and tertiary structure
levels, obtained by circular dichroism and fluorescence. First,
based on the 15N chemical shift deviation plot, residues showing
higher conformational deviations have higher secondary and
tertiary structure fluctuation in the crystal structures (Figure 4A
and Figure 5). Particularly, the residues close to residue 46 (b3)
and the hydrophobic pocket show more pronounced changes in
NMR signal position (Figure 4A). Second, while the L46G
mutant has the most drastic effect on the protein secondary
structure, the L46F mutation destabilization is slightly observed at
the b-strand b3 and at the C-terminus of the a-helix H1 due to an
accumulation of mechanical strain caused by higher steric
repulsion upon mutating the Leu46 to phenylalanine
(Figure 5B). Thus, decreasing the hydrophobicity of residue 46
(via mutations L46A and L46G) destabilizes the hydrophobic
pocket and results in distant structural perturbation that is
transmitted through the backbone, affecting the tertiary structure
of the MIF. Henceforth, the hydrophobic interactions at the
Leu46 pocket appear to play important role for the conformational
properties and stability of MIF.
MD Simulations Reveal High Level of Fluctuations at the
Leu46 Pocket
To further investigate the dynamic properties of the wt and
Leu46 MIF mutants, we carried out 100 ns MD simulations on
the wt, L46F, L46A, and L46G huMIF. Previous NMR
experiments performed by other groups had demonstrated that
the N-terminus of a-helix H1 (where Leu46 hydrophobic pocket is
located) is a highly fluctuating region compared to other parts of
wt huMIF: residues located at the N-terminus of H1 exhibit
internal motions on the 1–3 ns timescale [50]. In concordance
with these findings, our MD simulations showed that this same
region exhibits a high flexibility (Figure S4). These data imply
that the structural fluctuations within the Leu46 hydrophobic
pocket could be involved in the regulation of MIF structure and
possibly its function. A notable point about a-helix H1 is the
existence of Pro15 within the four N-terminal residues. Proline
residue, with very few exceptions, is located in the N-terminus of
a-helices, and act as a structural disrupting or switching element of
the helix [33]. In our case, MD simulations suggest that the Leu46
hydrophobic pocket fluctuations are caused by shortening and
extension of the a-helix H1 due to Pro15, which acts as a switching
element (Figure 6). Interestingly, MIFs crystallised from different
species, where both Leu46 hydrophobic site and Pro15 are
conserved, (Figure 1) have shortened a-helix H1. Only Leishmania
proteins (LmjMIF1 and LmjMIF2), where Lys15 substitutes
Pro15, crystallize with an extended H1. Richardson and co-
workers [64] reported structural differences between Leishmania
MIF species 1 and 2 and mouse MIF. Parasitic MIFs appear to
differ in two key regions from other MIF structures [64]. The a-
helix H1 constitutes one of these regions, which extends from
residues 13 to 31 in both LmjMIF structures but is significantly
shorter in mouse and other species structures (Figure S5).
Fluctuation of Leu46 Pocket Modulates the
Conformation of the Enzymatic Pocket
Using hydroxyphenylpyruvate as a substrate, we showed that all
Leu46 mutants are enzymatically active. Nonetheless, measure-
ments of the catalytic constants revealed that Leu46 mutations
exhibit different effects on MIF’s catalytic activity (Table 1). The
L46A mutant exhibits very similar catalytic activity and affinity
towards the substrate as wt huMIF. L46G yields a slight decrease in
huMIF affinity towards hydroxyphenylpyruvate, while L46F
mutation leads to increase in MIF’s affinity and catalytic activity.
Our data prove that stability of the Leu46 pocket is necessary for the
enzymatic activity of the protein. To rationalize the enzymatic data
obtained, we sought to acquire structural insights from NMR
spectroscopy. Our NMR results demonstrate that the chemical
environment at the enzymatic pocket is changed upon mutating the
residue Leu46 (Figure 4). The structural changes of a-helix H1 are
transmitted to residues 35–37 (C-terminus of H1) (Figure 6), and
trigger a geometric rearrangement of the enzymatic pocket.
Implications for MIF’s Biological Activity
Despite the fact that we did not investigate the role of Leu46
hydrophobic chamber in regulating MIF’s biological activities, it is
important to note that previous studies have suggested that residues
involved in formation of the pocket as being essential to MIF’
functions in CXCR2 mediated inflammatory and atherogenic
leukocyte recruitment [67]. Weber et al. reported about a pseudo-
(E)LR domain, that is located within the Leu46 chamber, and
suggested that this domain is crucial to MIF’s binding to CXCR2.
Substitutions of Arg11 and Asp44 by single (R11A) and double
mutations (R11A/D44A) severely abrogate CXCR2-mediated
functions of MIF in leukocyte recruitment in various in vitro, ex vivo
and in vivo models. Arg11 is a crucial component of the Leu46
hydrophobic site: it is located in the vicinity of Leu46 and forms a
sort of a ‘‘cap’’ to the pocket (Figure 1A, D); Asp44 is located very
close to the hydrophobic pocket, as it is adjacent to Pro43 that
belongs to the pocket (Figure 1D). Weber et al. also reported that
R11A and D44A single and double mutations do not affect the
secondary/tertiary structure of the protein, as assessed by circular
dichroism measurements; mutants also exhibited identical tauto-
merase activity towards D-dopachrome methyl ester. However, the
R11A mutant showed slightly more conformational stability than
the wt huMIF, as reflected by its mid-point of GdnHCl induced
unfolding. This suggests that mutation of Arg11 to a more
hydrophobic and less flexible residue could further stabilize the
hydrophobic pocket and therefore the entire protein.
Conclusions
Taken together, our data suggest that the intersubunit
interactions involving the residue Leu46 play a key role in the
structural stability of MIF and provide new insights into the role of
a novel intersubunit hydrophobic pocket in modulating MIF’s
conformation, stability, and potentially its receptor binding and
biological activity. It is plausible that molecules that effectively
compete for the Leu46 pocket and are also large enough to
interfere with intersubunit interactions could act as either
modulators of MIF activity or as trimer disruptors and more
effective drugs for neutralizing MIF in vivo.
Supporting Information
Figure S1 Thermal denaturation of wt and mutant MIF
is not concentration-dependant. Thermal unfolding studies
of wt huMIF (A), L46F huMIF (B), 46A huMIF (C) and L46G
huMIF (D) were monitored by far-UV CD at 218 nm. Proteins
were prepared in PBS 1X, pH 7.4. Solid lines, 30 mM; dashed
lines, 10 mM; dotted lines, 5 mM.
(TIFF)
Figure S2 Sedimentation rates of wt and Leu46 mutants
are independent of protein concentration, in the range
tested (5–50 mM). C(s) distributions of wt huMIF (A), L46F
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huMIF (B), L46A huMIF (C) and L46G huMIF (d) at 50 mM (solid
lines), 15 mM (dashed lines) and 5 mM (dotted lines).
(TIFF)
Figure S3 NMR chemical shift measurements demon-
strate a high similarity between L46A and L46G huMIF,
whereas the L46F mutant exhibits a slightly different
chemical shift pattern. (A) Two selected regions in 1H-15N
HSQC spectra are shown for residues with strong chemical shift
deviation. Color codes are as follows: wild-type in black, L46A
mutant in red, L46F mutant in green, L46G mutant in blue. (B)
Chemical shift differences between L46G MIF and wild-type MIF.
(C) Two-dimensional representation of chemical shift deviations of
mutant MIF from those of wild-type MIF. The gray square is
drawn at +/20.2 ppm in 15N, +/20.02 ppm in the 1H dimension
and separates very small from larger chemical shift changes.
(TIFF)
Figure S4 Root mean square fluctuations (RMSF, a
measure of the average atomic mobility) of the Ca atoms
during the molecular dynamics simulations of wt and
Leu46 mutants. Black line, wt huMIF; blue line, L46F huMIF;
red line, L46A huMIF; green line, L46G huMIF.
(TIFF)
Figure S5 MIF Leishmania homologues adopt extended
a-helix H1. (A) Superimposition of wt human and Leishmania
MIF monomers. Note the extension of the helix H1 in the
Leishmania species, in comparison to the crystal structure of the
human protein. (B) Multiple sequence alignment of wt huMIF and
the two species of Leishmania MIF. Residues highlighted in squares
correspond to the hydrophobic pocket, while residues underlined
correspond to the tautomerase enzymatic site.
(TIFF)
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